Pell Bio-Med Technology Co., Ltd. (TPE:6949)
Taiwan · Delayed Price · Currency is TWD 574.00
-3.00 (-0.52%)
Mar 13, 2026, 1:35 PM CST
Pell Bio-Med Technology Market Cap
Pell Bio-Med Technology has a market cap or net worth of 37.07 billion as of March 13, 2026. Its market cap has increased by 393.26% in one year.
Market Cap
37.07B
Enterprise Value
36.26B
Revenue
31.42M
Ranking
n/a
PE Ratio
n/a
Stock Price
574.00
Market Cap Chart
Since March 8, 2024, Pell Bio-Med Technology's market cap has increased from 5.56B to 37.07B, an increase of 567.12%. That is a compound annual growth rate of 156.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 37.07B | 84.76% |
| Dec 31, 2025 | 20.06B | 324.81% |
| Dec 31, 2024 | 4.72B | -15.00% |
| Mar 8, 2024 | 5.56B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lin BioScience | 32.47B |
| Oneness Biotech | 27.41B |
| Lumosa Therapeutics | 25.29B |
| Sunmax Biotechnology | 21.16B |
| Polaris Group | 18.57B |
| EirGenix | 17.16B |
| AP Biosciences | 14.89B |
| TaiMed Biologics | 13.82B |